What is the current Price Target for the Structure Therapeutics stock?

The average Structure Therapeutics target price is $76.50. This is 294.94% higher than the current stock price. The highest price target is 550.49%, the lowest is 160.71%. 15 Analysts have issued a price target Structure Therapeutics 2026 .

How high will the Structure Therapeutics stock rise?

No reliable answer can be given as to how high the Structure Therapeutics stock will rise. The performance of stocks, including the Structure Therapeutics stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Structure Therapeutics stock today?

The performance of Structure Therapeutics stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Structure Therapeutics stock fall?

The decline in Structure Therapeutics stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Structure Therapeutics Forecast, price target & analysts

$19.37

4.34% yesterday

Nasdaq, Aug 21, 10:00 pm CET

ISIN

US86366E1064

Symbol

GPCR

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Structure Therapeutics Target price 2025 - Analyst rating & recommendation

Structure Therapeutics Classifications & Recommendation:

Buy

95%

Hold

Structure Therapeutics Price Target

Target Price	$76.50
Price	$19.37
Potential	294.94% register free of charge
Number of Estimates	15

	15 Analysts have issued a price target Structure Therapeutics 2026 . The average Structure Therapeutics target price is $76.50. This is 294.94% register free of charge higher than the current stock price. The highest price target is $126.00 550.49% register free of charge , the lowest is $50.50 160.71% register free of charge .
	A rating was issued by 19 analysts: 18 Analysts recommend Structure Therapeutics to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Structure Therapeutics stock has an average upside potential 2026 of 294.94% register free of charge . Most analysts recommend the Structure Therapeutics stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.78	-1.07
	3.70%	37.18%
P/E		negative

14 Analysts have issued a Structure Therapeutics forecast for earnings per share. The average Structure Therapeutics EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.78	3.70%
2025	$-1.07 37.18% Unlock
2026	$-1.51 41.12% Unlock
2027	$-1.58 4.64% Unlock
2028	$-1.80 13.92% Unlock
2029	$-0.06 96.67% Unlock
2030	$1.44 2,500.00% Unlock
2031	$3.41 136.81% Unlock
2032	$6.63 94.43% Unlock

Current	-18.63	66.38%
2025	-18.04 3.14% Unlock
2026	-12.80 29.05% Unlock
2027	-12.23 4.45% Unlock
2028	-10.77 11.94% Unlock
2029	-316.50 2,838.72% Unlock
2030	13.45 104.25% Unlock
2031	5.67 57.84% Unlock
2032	2.92 48.50% Unlock

Structure Therapeutics...

Current Structure Therapeutics Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Guggenheim	Locked ➜ Locked	Locked	Aug 07 2025
JMP Securities	Locked ➜ Locked	Locked	Aug 07 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 07 2025
Cantor Fitzgerald	Locked ➜ Locked	Locked	Jun 23 2025
JMP Securities	Locked ➜ Locked	Locked	Jun 23 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	May 12 2025
Citigroup	Locked ➜ Locked	Locked	May 02 2025

Analyst Rating	Date
Locked Guggenheim: Locked ➜ Locked	Aug 07 2025
Locked JMP Securities: Locked ➜ Locked	Aug 07 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 07 2025
Locked Cantor Fitzgerald: Locked ➜ Locked	Jun 23 2025
Locked JMP Securities: Locked ➜ Locked	Jun 23 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	May 12 2025
Locked Citigroup: Locked ➜ Locked	May 02 2025

Discover more stocks with a high price target

Alibaba Group Holding Ltd 30.78%

Rheinmetall 28.98%

Coinbase Global, Inc. 27.38%

BioNTech SE - ADR 26.61%

Microsoft 26.43%

PayPal 24.57%

Deutsche Telekom 22.62%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now